Search Results for:
-
BioWorld's Top 10 Countdown of 2012's Most Impactful Stories
The year closed out with two large acquisition deals for genomics companies...Amgen plunked down $415 million to acquire DeCode Genetics, a genomics company that was threatened with bankruptcy liquidation just three years agoBy BioWorld Staff | BioWorld International | Wednesday, January 2, 2013 -
BioWorld's Top 10 Countdown of 2012's Most Impactful Stories
The year closed out with two large acquisition deals for genomics companies...Amgen plunked down $415 million to acquire DeCode Genetics, a genomics company that was threatened with bankruptcy liquidation just three years agoBy BioWorld Staff | BioWorld Today | Thursday, December 27, 2012 -
NewCo News: Translational Medicine on the Move at 2007 Start-up Kineta
Its success to date stems mainly from its founders, biotech veterans Charles Magness and Shawn Iadonato, who previously co-founded Illumigen Biosciences Inc., a genetics/genomics company bought by Cubist Pharmaceuticals IncBy Jennifer Boggs | BioWorld Today | Wednesday, September 21, 2011 -
SuperGen Merges with Astex in $120M Cash, Stock Deal
In November 2003 it acquired MetaGen Pharmaceuticals GmbH, accessing the £15 million cash pile of the Berlin-based genomics company and raising £8 million privately at the same timeBy Nuala Moran | BioWorld International | Wednesday, April 13, 2011 -
SuperGen Merges with Astex in $120M Cash, Stock deal
In November 2003 it acquired MetaGen Pharmaceuticals GmbH, accessing the £15 million cash pile of the Berlin-based genomics company and raising £8 million privately at the same timeBy Nuala Moran | BioWorld Today | Friday, April 8, 2011 -
Beyond Outsourcing: Asia Offers Deals, Dollars, Demographics
She likened the trend to how early genomics companies began as service providers but eventually transitioned to drug developmentBy Trista Morrison | BioWorld Today | Wednesday, June 17, 2009 -
Beyond Outsourcing: Asia Offers Deals, Dollars, Demographics
She likened the trend to how early genomics companies began as service providers but eventually transitioned to drug developmentBy Trista Morrison | Bio Perspectives | Tuesday, June 16, 2009 -
Papers Agree on Lung Cancer Risk Genes, Disagree on Why
The first paper, by researchers from Icelandic genomics company deCode Genetics, did a genomewide association study of about 14,000 smokers and found two SNPs that correlated with increased nicotine dependence as well as an increased risk of lung cancer and peripheral arterial diseaseBy Anette Breindl | BioWorld Today | Thursday, April 3, 2008 -
Start-Up Pharnext Raises €2.5M For Drug Repositioning Effort
The chairman, CEO and co-founder of Pharnext is Daniel Cohen, who spent a significant part of his past career with the French genomics company Genset until it was taken over by the Swiss pharmaceutical company Serono in 2002By James Etheridge | BioWorld International | Wednesday, December 12, 2007 -
2006 Biotechnology Mergers And Acquisitions
COMPLETED MERGERS AND ACQUISITIONS FIRST QUARTER Company Acquired (Country Symbol) Acquired By Or Merged With (Country Symbol) Date Announced Date Completed Value (M)*** Terms/Details Agowa AG* (Germany) LGC Group (UK) 1/12/06 1/12/06 ND LGC extended its European operations through the acquisition of Agowa, a genomics company in Germany Agribiotics Holdings Inc.* (Canada) Nitragin Holding Inc. (Canadian affiliate of Merck KGaA) 3/28/06 3/28/06 €20 ($24) Nitragin acquiredState of the Industry Report | Wednesday, May 23, 2007 -
Weak Dollar Good For Biotech: Outsourcing Trend May Reverse
But outsourcing isn't the real story here, any more than contract services was the full story of combichem or genomics companiesBy Cynthia Robbins-Roth | BioWorld Today | Monday, December 18, 2006 -
Other News To Note
Nanogen Inc., of San Diego, formed a collaboration with Oy Jurilab Ltd., a Kuopio, Finland-based genomics company, to identify and validate new prognostic markers for Type II diabetesBioWorld Today | Tuesday, May 16, 2006 -
Biotech Mergers And Acquisitions: Dec. 29, 2005-March 29, 2006#
the combined firm assumed the Advanced Ocular Systems name and headquarters Agowa AG* (Germany) LGC Group (UK) 1/12/06 1/12/06 ND LGC extended its European operations through the acquisition of Agowa, a genomics company in Germany Agribiotics Holdings Inc.* (Canada) Nitragin Holding Inc. (Canadian affiliate of Merck KGaA) 3/28/06 3/28/06 €20 ($24) Nitragin acquired Agribiotics, a crop bio- science company Research products division of Ambion Inc.* Applied Biosystems Group 12/27/05 3BioWorld Insight | Monday, April 3, 2006 -
Other News To Note
LGC Group, of London, acquired Agowa AG, of Berlin, Germany, a genomics companyBioWorld International | Wednesday, January 18, 2006 -
Biotech Mergers And Acquisitions
January | February | March | April | May | June | July | August | September | October | November | December COMPLETED MERGERS AND ACQUISITIONS - December 2006 Company Acquired Acquired By Or Merged With Date Announced Date Completed Value (M) Terms/Details Connetics Corp. (CNCT) Stiefel Laboratories Inc. 10/23/06 12/28/06 $670 Stiefel paid $17.50 per share in cash, or $670M, for Connetics; the offer was a 62% premium to the four-week average price Elbion AG (GermanyBioWorld Snapshots | Wednesday, January 11, 2006 -
A Cell Break Masterminded By The Mapping Of The Human Genome
Other genomics companies, but especially industry investors, were unsure what impact the project's completion would have on the industry as a whole, so it became a cautious market until the post-HGP impact could be analyzedBy Michael J. Harris | RNAi Report | Monday, November 7, 2005 -
U.S. Firm Amphion Capital Goes Public With £5M Listing On AIM
Those include Motif Biosciences, a population genomics company using genomics data from the Arabian Gulf region to research common disordersBy Nuala Moran | BioWorld International | Wednesday, August 24, 2005 -
Nuvelo's Secreted Protein Find Leads To Agreement With Kirin
The discovery of NU206 also represented a "significant achievement" for Nuvelo as it is the first product candidate identified through its own internal research efforts, Love said, marking the company's final transition "from a genomics company to a company that actually develops therapeutics using genomicsBy Jennifer Boggs | BioWorld Today | Tuesday, April 5, 2005 -
Exelixis Drops Ag Joint Venture, Gets $21M To Focus On Pipeline
The reason is we obviously have evolved from a genomics company to having what we think is one of the most promising early stage pipelines," said Charles Butler, the company's associate director of corporate communicationsBy Karen Pihl-Carey | BioWorld Today | Monday, April 4, 2005 -
Allergy Therapeutics Raises £15M On AIM In London IPO
The Oxford-based chemical genomics company joined AIM with a market capitalization of £42.3 millionBy Nuala Moran | BioWorld International | Wednesday, October 13, 2004
Category
Current Filters
- xgenomics company
Related Keywords
Categories
- x BioWorld Today (223)
- x BioWorld International (121)
- x BioWorld Genomics Review (69)
- x BioWorld Insight (22)
- x State of the Industry Report (9)
- x BioWorld Snapshots (3)
- x Bio Perspectives (1)
- x RNAi Report (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.